StockData

ProPhase Labs, Inc. (PRPH) stock

PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.01−0.00 (-6.16%)

Close on Oct 19, 2026Market cap $119.68KP/E –Yield –

ProPhase Labs revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ProPhase Labs's revenue for the twelve months ending Jun 30, 2026 was $3.85M, down 31.2% year over year. For fiscal 2025 it was $4.35M, down 35.8% from the year before. Over ten years it grew 5.6% a year on average. The highest annual figure on record is $122.65M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.35M-35.8%
FY2024Dec 31, 2024$6.77M-80.6%
FY2023Dec 31, 2023$34.98M-71.5%
FY2022Dec 31, 2022$122.65M+55.2%
FY2021Dec 31, 2021$79.04M+444.6%
FY2020Dec 31, 2020$14.51M+47.0%
FY2019Dec 31, 2019$9.88M-24.8%
FY2018Dec 31, 2018$13.13M+33.0%
FY2017Dec 31, 2017$9.87M+134.6%
FY2016Dec 31, 2016$4.21M+67.0%
FY2015Dec 31, 2015$2.52M-88.6%
FY2014Dec 31, 2014$22.07M-11.8%
FY2013Dec 31, 2013$25.03M+11.7%
FY2012Dec 31, 2012$22.41M+28.4%
FY2011Dec 31, 2011$17.45M+20.3%
FY2010Dec 31, 2010$14.50M-26.8%
FY2009Dec 31, 2009$19.82M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.01M-18.9%
Q1 FY2026Mar 31, 2026$1.17M-18.3%
Q4 FY2025Dec 31, 2025$784.00K-47.5%
Q3 FY2025Sep 30, 2025$883.00K-37.6%
Q2 FY2025Jun 30, 2025$1.25M-17.1%
Q1 FY2025Mar 31, 2025$1.43M-39.3%
Q4 FY2024Dec 31, 2024$1.49M-57.3%
Q3 FY2024Sep 30, 2024$1.42M-83.1%
Q2 FY2024Jun 30, 2024$1.50M-88.6%
Q1 FY2024Mar 31, 2024$2.36M-87.8%
Q4 FY2023Dec 31, 2023$3.50M-84.0%
Q3 FY2023Sep 30, 2023$8.37M-65.4%
Q2 FY2023Jun 30, 2023$13.22M-54.6%
Q1 FY2023Mar 31, 2023$19.30M-59.4%
Q4 FY2022Dec 31, 2022$21.82M-51.7%
Q3 FY2022Sep 30, 2022$24.20M+154.7%
Q2 FY2022Jun 30, 2022$29.09M+219.7%
Q1 FY2022Mar 31, 2022$47.53M+210.7%
Q4 FY2021Dec 31, 2021$45.14M+774.3%
Q3 FY2021Sep 30, 2021$9.50M+147.4%
Q2 FY2021Jun 30, 2021$9.10M+151.2%
Q1 FY2021Mar 31, 2021$15.30M+710.4%
Q4 FY2020Dec 31, 2020$5.16M+64.4%
Q3 FY2020Sep 30, 2020$3.84M+38.8%
Q2 FY2020Jun 30, 2020$3.62M+119.4%
Q1 FY2020Mar 31, 2020$1.89M-18.6%
Q4 FY2019Dec 31, 2019$3.14M-23.3%
Q3 FY2019Sep 30, 2019$2.77M+13.4%
Q2 FY2019Jun 30, 2019$1.65M-48.2%
Q1 FY2019Mar 31, 2019$2.32M-32.0%
Q4 FY2018Dec 31, 2018$4.09M-1.4%
Q3 FY2018Sep 30, 2018$2.44M-19.8%
Q2 FY2018Jun 30, 2018$3.19M+67.2%
Q1 FY2018Mar 31, 2018$3.41M+341.9%
Q4 FY2017Dec 31, 2017$4.15M+441.2%
Q3 FY2017Sep 30, 2017$3.04M+116.8%
Q2 FY2017Jun 30, 2017$1.91M–
Q1 FY2017Mar 31, 2017$771.00K–
Q4 FY2016Dec 31, 2016$767.00K–
Q3 FY2016Sep 30, 2016$1.40M–

More ProPhase Labs figures

See a number that looks wrong?